These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 26214117
21. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations. Hawkes CP, Li D, Hakonarson H, Meyers KE, Thummel KE, Levine MA. J Clin Endocrinol Metab; 2017 May 01; 102(5):1440-1446. PubMed ID: 28324001 [Abstract] [Full Text] [Related]
22. Maternal Hypercalcemia Due to Failure of 1,25-Dihydroxyvitamin-D3 Catabolism in a Patient With CYP24A1 Mutations. Shah AD, Hsiao EC, O'Donnell B, Salmeen K, Nussbaum R, Krebs M, Baumgartner-Parzer S, Kaufmann M, Jones G, Bikle DD, Wang Y, Mathew AS, Shoback D, Block-Kurbisch I. J Clin Endocrinol Metab; 2015 Aug 01; 100(8):2832-6. PubMed ID: 26097993 [Abstract] [Full Text] [Related]
25. [A young girl with recurrent calculosis and hypercalcemia]. Di Maio F, Vittori M, Bassi P, Fulignati P, D'Alonzo S, Ferraro PM. G Ital Nefrol; 2018 May 01; 35(3):. PubMed ID: 29786188 [Abstract] [Full Text] [Related]
26. Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure. Colussi G, Ganon L, Penco S, De Ferrari ME, Ravera F, Querques M, Primignani P, Holtzman EJ, Dinour D. Nephrol Dial Transplant; 2014 Mar 01; 29(3):636-43. PubMed ID: 24235083 [Abstract] [Full Text] [Related]
28. 3' Untranslated Region Structural Elements in CYP24A1 Are Associated With Infantile Hypercalcemia Type 1. Ball N, Duncan S, Zhang Y, Payet R, Piec I, Whittle E, Tang JCY, Schoenmakers I, Lopez B, Chipchase A, Kumar A, Perry L, Maxwell H, Ding Y, Fraser WD, Green D. J Bone Miner Res; 2023 Mar 01; 38(3):414-426. PubMed ID: 36625425 [Abstract] [Full Text] [Related]
29. Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D3 and related intermediates in serum of mice treated with 24,25-dihydroxyvitamin D3. Kaufmann M, Martineau C, Arabian A, Traynor M, St-Arnaud R, Jones G. J Steroid Biochem Mol Biol; 2019 Apr 01; 188():23-28. PubMed ID: 30553931 [Abstract] [Full Text] [Related]
34. A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass. Ferraro PM, Minucci A, Primiano A, De Paolis E, Gervasoni J, Persichilli S, Naticchia A, Capoluongo E, Gambaro G. Urolithiasis; 2017 Jun 01; 45(3):291-294. PubMed ID: 27639704 [Abstract] [Full Text] [Related]
35. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase. Tenenhouse HS, Jones G. Endocrinology; 1987 Feb 01; 120(2):609-16. PubMed ID: 3803293 [Abstract] [Full Text] [Related]